Despite the Final Rule mandate for equitable organ allocation in the United States, geographic disparities exist in donor lung allocation, with the majority of donor lungs being allocated locally to lower-priority candidates. We conducted a retrospective cohort study of 19 622 lung transplant candidates waitlisted between 2006 and 2015.
We used multivariable adjusted competing risk survival models to examine the relationship between local lung availability and waitlist outcomes. The primary outcome was a composite of death and removal from the waitlist for clinical deterioration. 
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clinical research/practice, donors and donation, ethics, health services and outcomes research, lung transplantation/pulmonology, organ allocation, organ procurement and allocation, United Network for Organ Sharing (UNOS), waitlist management with inclusion of both predicted waitlist and posttransplantation 1-year survival in its calculation. 1, 4, 5 Unfortunately, the new lung allocation system failed to address geographic restrictions in lung allocation. 4, 6, 7 Currently, donor lungs are first offered to candidates within a local donation service area (DSA) and only offered to candidates outside a DSA in predefined zones of 500 nautical miles extending from the donor hospital if there is no local transplant center or if the local transplant center(s) reject the donor lungs. [7] [8] [9] As a result, it has been demonstrated that lungs are primarily allocated locally to lower-priority candidates with a lower LAS when higher-priority candidates are available regionally, which runs counter to the intent of the Final Rule. 7, 9, 10 The geographic differences in local donor lung supply and average waitlist times for lung transplantation are well known, with data regularly updated and published by the Scientific Registry for Transplant Recipients. 7, 11 However, the effect that these local differences in donor lung supply have on waitlist outcomes has not been fully described or quantified. Differences in donor lung supply are not comparable in isolation, due to differences in waitlist sizes, local population served, and disease demographics. In this study, we coined the term "local lung availability" to describe local donor lung supply defined as the ratio of local donor lungs to waitlist candidates within a DSA. We tested the hypothesis that lung transplant candidates in areas of low local lung availability have increased waitlist mortality and lower transplantation rates.
| MATERIALS AND METHODS

| Study design, participants, and data sources
This is a retrospective cohort study of all adolescents older than 12 years and adults on the waitlist in the United States from January 
| Analytical approach
Baseline characteristics across quartiles were examined by using the imputations with chained equation were used for comparison and is shown in the online supporting information (Table S1 ). In our primary analysis, we did not use listing center as an adjustment factor because it was highly correlated with geography as most listing centers are in separate DSAs. To evaluate for bias, we constructed additional analyses with adjustment for listing center, with censoring at end of follow-up rather than 1 year and without exclusion of inactive DSAs;
all analyses are shown in the online supporting information (Table S1 ).
Death/removal and transplantation rates were evaluated by using a competing risk model clustered based on DSA. Predicted cumulative incidence function curves were generated by quartiles of local lung availability using Stata version 14.1 (StataCorp, College Station, TX).
The proportional hazards assumption was evaluated by examining for time-varying covariates. 16 T A B L E 1 (Continued) Figure 1 shows the large variation in local lung availability, re- 
| RESULTS
| Lung availability and waitlist outcomes
The greatest number of deaths/removals occurred in the lowest quartile of local lung availability with the number of events decreasing as local lung availability increased (750, 629, 585, and 457 deaths/ removals in quartiles 1-4, respectively; Table 2 Table 2 ). The adjusted transplantation rate increased by 19% with a 50% increase in local lung availability (SHR: 1.19, 95% CI: 1.17-1.22, P < .001).
Cumulative incidence curves for death/removal and transplantation are shown in Figure 2 . Analyses using multiple imputation for rare missing data, censoring at end of follow-up rather than 1 year, and adjustment for listing center all produced similar results as the primary analysis and are shown in the online supporting information (Table S1 ).
| Subgroup analysis
Stratified analysis is shown in Figure 3 , and a complete stratified analysis is shown in the online supporting information (Table S2) 1.01-1.11, P = .018).
Stratified analysis based on LAS group is shown in Table 3 . In lung transplant candidates with the highest LAS (LAS ≥ 80), the effect of lower local lung availability was still detrimental but less so compared with the lower LAS groups. The adjusted rate of Table 3 ). The effect was similar with transplantation rates.
Candidates in the highest LAS group had a 9% increase in transplantation rate with a 50% increase in local lung availability (SHR: 1.09, 95% CI: 1.0-1.14, P < .001). This was different from candidates with a low LAS (LAS < 40) who had a 25% increase in transplantation rate with a 50% increase in local lung availability (SHR: 1.25, 95%
CI: 1.21-1.29, P < .001).
| DISCUSSION
In our investigation of the lung allocation system in the United States, we found that low local lung availability, defined as the ratio of donor lungs to waitlist candidates in a DSA, is independently associated with higher rates of death/removal and lower transplantation rates among persons listed for lung transplantation. This study demonstrates that the current system results in an unfair distribution of lungs and geographically disparate outcomes for candidates who are listed for transplantation in areas with less local donor lungs and/or larger number of waitlist candidates.
F I G U R E 2 Cumulative incidence curves. Predicted cumulative incidence curves for death or removal for clinical deterioration (A) and transplantation (B) by quartiles of local lung availability F I G U R E 3 Multivariable adjusted subdistribution hazard ratios (SHRs) for a 50% increase in local lung availability. Forrest plots of associations between local lung availability and transplantation rate and death or removal for deterioration stratified by selected clinical variables. Circles represent point estimates for the multivariable adjusted SHR for a 50% increase in local lung availability. The lines are 95% confidence intervals. LAS, lung allocation score; COPD, chronic obstructive pulmonary disease; PVD, pulmonary vascular disease; CF, cystic fibrosis; ILD, interstitial lung disease; ECMO, extracorporeal membrane oxygenation usage; Vent, mechanical ventilation use; Double Only, listed for only bilateral lung transplant; Crossmatch, prospective cross-match required at listing. Adjusted for confounders, including age, sex, race, diagnosis, body mass index (BMI), mechanical support with ECMO or mechanical ventilation, blood type, LAS, height, population of DSA, new registrations/activations on waitlist during next year in the DSA, lungs imported from another DSA for transplantation, oxygen requirement at listing, double lung requirement, and physical cross-match requirement Lung allocation in the United States is primarily a local process within boundaries of DSAs. There are currently 58 DSAs, which do not encompass equal population size or land mass and often have arbitrary boundaries that do not follow state borders. 6, 7, 17 Prior work by Russo et al revealed that most donor lungs are allocated to candidates with LAS <50 who have the lowest waitlist mortality and obtain the least net benefit from lung transplantation. 12 This phenomenon occurs due to geographic restriction and locally based allocation of lungs. Indeed, Russo and colleagues showed that in 580 bilateral lung transplant recipients in 2009, lungs were commonly allocated to a lower-priority local candidate despite the existence of an ABO-and size-matched regional candidate with a higher LAS. 9 Although it has long been observed that geographic disparities exist in the donor lung supply, this is the first study to demonstrate and quantify the effect that local lung availability has specifically on waitlist outcomes. 6, 7, 9 We newly coined the term "local lung availability" because a low local lung supply is obviously less deleterious for candidates if there are fewer persons competing for lungs on the waitlist. We found dramatic variation in local lung availability across
DSAs as shown by a >600% difference in median local lung availability across the quartiles. Compared with this difference among quartiles, a relatively small increase in local lung availability of 50% will produce substantial changes to death/removal and transplantation rates. The current allocation system does allow transplant centers to gain access to a potentially life-saving donor lung supply by retrieving lungs outside their DSA. 18, 19 However, these lungs become available only after being turned down by the local center or from a DSA without a local transplant center. 18, 19 One of the interesting findings in our exploratory analysis was the effect that local lung availability had on candidates with both the lowest and highest LAS at listing (<40 and ≥80). Differences in local lung availability had less drastic effects on waitlist death/removal and transplantation rates in candidates with very high LAS at listing. This same effect was seen in candidates who were receiving ECMO or mechanical ventilation at the time of listing. As the local lung availability increased, waitlist candidates with a low LAS (<40) had a greater increase in transplantation rate and reduction in death/removal rate compared with candidates with very high LAS (≥80). These results suggest that the current allocation system offers greater benefits to candidates with low LAS solely based on the happenstance of geography.
Allocation of lungs based on LAS rather than geographic restrictions imposed by DSAs would lead to distribution based on need, which is more consistent with the intent of the Final Rule.
The Scientific Registry of Transplant Recipients publishes annual reports detailing waitlist time, waitlist mortality and transplantation rate of all transplant programs. 20 Notably, these annual reports highlight waitlist mortality and transplant rates and compare them with the national average and the "expected rates," but they do not account for differences in local lung availability. 11 Currently, candidates can view online these publically available reports of median waiting time, waitlist mortality, and transplantation rates. Candidates with greater financial resources can then take advantage of the system by listing at >1 transplant center in different DSAs and gain access to a larger donor lung supply. 21 This phenomenon puts into question the justice principle of transplant ethics, which is founded on equitable allocation of organs to all patients medically qualified for transplantation.
22,23
Our study does not attempt to evaluate organ procurement organization performance and does not account for all potential donors who could become real donors if they were registered, consented, and were managed differently. Although this represents a major public health problem in need of significant initiatives, it is beyond the scope of our investigation. Ultimately, patients should not be penalized for being able to access only a transplant center that has a low local donor lung supply, whether it is due to poor donation rates, different causes of death, or poor organ procurement organization performance. Our study does not address differences in access to waitlist by patients, but it certainly demonstrates that lungs are not being shared equitably among those who make it to the waitlist. Others have demonstrated that there are geographic differences in access to the waitlist, which certainly warrants further evaluation. 6 It is important to acknowledge that transplant centers have the ability to augment their local lung supply through a more aggressive approach to donor management and acceptance of lungs from extended donors. In addition, transplant centers that are willing to travel long distances to evaluate and "import" donor lungs can further increase their lung supply. We attempted to account for this in our model by calculating and adjusting for imported lungs obtained from outside the DSA. As one would expect, DSAs with low local lung availability also had more imported lungs for transplantation. Despite the adjustment for imported lungs in our analysis, there remained significant differences in waitlist outcomes attributable to local lung availability.
Our study has several limitations. First, all measurements were reported by clinical personnel to the OPTN and are subject to missingness and inaccuracy, including specifically the primary outcome of death. 16 Second, the models do not address predictors of outcomes that are not collected by OPTN. Third, our study did not include pediatric candidates younger than 12 years because lungs are allocated differently in this age group. 1, 3, 24 Fourth, the primary predictor variable, local lung availability, may be affected by differences in waitlist size due to local center listing behavior and by differences in donor lung supply due to transplant center criteria for donor lung acceptance. It is possible that centers in low lung availability DSAs do not list patients with low LAS due to low transplantation rates. In this case, our study would underestimate the magnitude of the disparity regarding differences in mortality and transplantation rates. Fifth, there are multiple ways to assess waitlist size, and we used waitlist size at the time of transplantation as the waitlist measure in the local lung availability ratio because we thought that this best captured the overall competition for lungs in the patient's local DSA at the time the candidate was placed on the removal rates and lower rates of transplantation. Although implementation of the LAS has been a success by decreasing waitlist time and mortality, it has not addressed geographic disparities in access to lung transplantation. UNOS has acknowledged this disparity in kidney, liver, and heart allocation, 17, 25, 26 and our study suggests that a change in lung allocation devoid of artificial geographic borders would be more consistent with the intent of the Final Rule. 
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